Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human HSD17B7 Antibodies:
anti-Mouse (Murine) HSD17B7 Antibodies:
anti-Rat (Rattus) HSD17B7 Antibodies:
Go to our pre-filtered search.
Inhibition of 17beta-HSD (show HSD17B3 Antibodies) 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78 (show HSPA5 Antibodies).
Substrate inhibition of 17beta-HSD1 (show SPAG8 Antibodies) in tumor epithelial cells and regulation of 17beta-HSD7 by 17beta-HSD1 (show SPAG8 Antibodies) knockdown has been demonstrated.
17beta-HSD1 (show SPAG8 Antibodies) and 17beta-HSD7 are principal reductive 17beta-hydroxysteroid dehydrogenases and major players in the viability of estrogen-dependent breast cancer cells.
The transcriptional activity of the HSD17B7 gene containing the G allele is higher than that of the C allele. This difference in HSD17B7 expression may regulate the risk of peripheral edema as an adverse reaction induced by estramustine phosphate sodium
Data show that apicidin significantly lowers HSD17B1 (show HSD17B1 Antibodies) transcript and protein levels in endometrial adenocarcinoma cells, with no significant effect on HSD17B1 (show HSD17B1 Antibodies) transcript stability.
estradiol stimulates HSD17B7 transcriptional activity in breast cancer cells through a novel mechanism requiring NF1 (show NF1 Antibodies) and strongly suggest a positive feedback mechanism, increasing estradiol synthesis causing growth of estrogen-dependent breast cancers
increased expression of HSD17B7 is associated with breast cancer.
HSD17B7 is a novel candidate for inborn errors of cholesterol metabolism
The identified proximal promoter regions of both human and murine HSD17B7 genes contain multiple transcription factor binding sites and show strong similarity to cholesterogenic genes.
Results provide unequivocal evidence for a role of 17beta-hydroxysteroid dehydrogenase type-7 in cholesterol biosynthesis.
a recessive mutation, rudolph, that causes abnormal forebrain development was identified in hydroxysteroid (17-beta) dehydrogenase 7 gene, an enzyme necessary for cholesterol biosynthesis.
Hsd17b7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos
Data show that prolactin receptor-associated protein (show S100A6 Antibodies)/17beta-hydroxysteroid dehydrogenase type 7 plays an important role in fetal survival and embryonic development in mice.
HSD17B7 encodes an enzyme that functions both as a 17-beta-hydroxysteroid dehydrogenase (EC 18.104.22.168) in the biosynthesis of sex steroids and as a 3-ketosteroid reductase (EC 22.214.171.1240) in the biosynthesis of cholesterol (Marijanovic et al., 2003
, 17-beta hydroxysteroid dehydrogenase
, hydroxysteroid (17-beta) dehydrogenase 7
, 17-beta-hydroxysteroid dehydrogenase type 7
, 3-keto-steroid reductase-like
, 17 beta-hydroxysteroid dehydrogenase type VII
, 17-beta-HSD 7
, 17-beta-hydroxysteroid dehydrogenase 7
, 17beta hydroxysteroid dehydrogenase
, estradiol 17-beta-dehydrogenase 7
, short chain dehydrogenase/reductase family 37C, member 1
, PRL receptor-associated protein
, hydroxysteroid dehydrogenase 17 beta, type 7